TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Improvement in mMASI SCORE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in clients' decision-making autonomy
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in clients' met need for family planning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Generalized Anxiety Disorder Questionnaire Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Pittsburgh Sleep Quality Index Questionnaire Score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: 4-meter Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5 Times Sit and Stand Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linguistic performance in syntax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and prevalence of RVD and RHF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of objectively proven VTE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Revised Impact of Event Scales (IES-R)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Modified Quick Speech-in-Noise Test (mQuickSIN) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abbreviated Profile of Hearing Aid Benefit (APHAB)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants with Treatment Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Satisfaction with the treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of clinically important changes in ECG parameters
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of clinically important changes in laboratory tests
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of clinically significant changes in vital signs
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of changes in the Columbia-Suicide Severity Rating Scale (C-SSRS)
Endpoint domain: Adverse events/effects
Primary endpoint: Knowledge regarding Caries Risk Assessment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attitude regarding Caries Risk Assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Practice regarding Caries Risk Assessment
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Serum Ferritin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total Iron-Binding Capacity (TIBC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Transferrin Saturation (tSAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: High Sensitivity C-Reactive Protein (hs-CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Audiometry change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior Chamber Cell (ACC) grade on Day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mCLA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 25-hydroxy vitamin-D level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients with persistent culture-positive sputum
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum observed plasma concentration (Cmax) of ATH-1017/ATH-1001
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to maximum observed plasma concentration (Tmax) of ATH-1017/ATH-1001
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration time curve (AUC) for ATH-1017/ATH-1001
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concurrent validity of K-Force Plates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Controlled attenuation parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Kidney Disease Quality of Life - 36 (KDQOL-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in 'Zarit' burden Interview (ZBI)
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: The area under the plasma drug concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Diabetes Distress levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient fatigue as assessed with the fatigue severity subscale of the Checklist Individual Strength (CIS-fatigue)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Number of videos viewed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of completed daily ratings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Urine excretion of [4-14C]AEF0117
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Feces excretion of [4-14C]AEF0117
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the concentration-time curve of AEF0117
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in insomnia severity index (ISI) score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Mean change in subject sleep efficiency (sSE)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Overall safety of the Exablate BBBD procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects achieving GTR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Correct size selection of LMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to pain resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Molecular Remission (CMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who have tested for HIV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of participants who have engaged in condomless anal intercourse
Endpoint domain: Adverse events/effects
Primary endpoint: trunk muscles strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: core muscle endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histological clearance of treated SCCis lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of any complications
Endpoint domain: Adverse events/effects
Primary endpoint: Mean diameter of the Intradermal Challenge Late Phase Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pre-extubation LUS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from Baseline on Short Physical Performance Battery (SPBB)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Unified Parkinson's Disease Rating Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tinetti balance and gait score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with positive AI-ECG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in inhibitory control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in executive function processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frequency of adverse events (AEs) and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: PFS in dose expansion
Endpoint domain: Mortality/survival
Primary endpoint: Change from Baseline JFK Coma Recovery Scale-Revised (CRS-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Post-PVI FFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent of participants experiencing grade 3+ adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Neonatal Infant Motor Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: conversion rate to open surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Change of OM incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Use of safe water
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child (12 years and under) growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Differences in mortality between responders and non-responders to guideline-directed medical therapy
Endpoint domain: Mortality/survival
Primary endpoint: Differences in morbidity between responders and non-responders to guideline-directed medical therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention measure by Choice Reaction Time task (CRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SARA Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: HHT Baseline Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HHT Clinical Outcomes Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Schober test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in Blood Levels of Vitamin B12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Blood Levels of Insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Blood Levels of Vitamin D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Blood Levels of Iron
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in healthy marriage/relationship communication skills scores
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Improvement in conflict management/resolution skills scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in attitudes about personal finances scores
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Improvement in job/career skills score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Incidence of COVID-19 disease progression
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of participants who were eligible and enrolled in the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of participants retained in the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Injury-related fear as measured by the Tampa Scale of Kinesiophobia-11
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Difference of pain score before and after interscalene block resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of rebound pain
Endpoint domain: Adverse events/effects
Primary endpoint: Change in mean left ventricle ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acute adverse events definitely or probably related to radiation therapy at 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: Change in free-fat soft tissue mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of the structured light
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radius of the radial retinal polarizer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Free Fatty Acid (FFA) release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cellular immune status via flow-cytometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cellular immune status on tissue samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cellular free DNA measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HMGB1 measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morphological tumor characteristics evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Michigan Incontinence Symptom Index (M-ISI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean level of improvement in NLF severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of CVC Placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total Tic Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of pigmented skin lesions as benign or malignant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Scoring of pigmented skin lesions using 2D FotoFinder® Mole Analyzer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Scoring of pigmented skin lesions using 3D Vectra® WB360 imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Scoring of pigmented skin lesions using Smartphone app Skin Vision®
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: positive predictive value (PPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: negative predictive value (NPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tumor Regression Grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time of gastric emptying
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: New onset clinically significant disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Efficacy in managing acute wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Nutrition Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Baseline Heart Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of participants achieving castrate levels of serum testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage of participants maintaining the castrate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Overall attendance/adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changes in the Intervention acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Development of parasitaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Parasite multiplication rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Age of walking attainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: User experience from parents
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effect of periodontal treatment on SLE patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients who initiated dacomitinib at different doses
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients that experience dose modification
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients that experience dose interruption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients that experience dose discontinuation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mean nasal soft tissue envelope thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of small intestinal mucosal lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Observance of sickle cell patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of diary completion
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: Binocular best-corrected visual acuity (BCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Patients with Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Patients with Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Victorian Institute of Sport Assessment-Patella (VISA-P)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Limb functional Index (LLFFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RPE (Rating Perceived Exertion)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Threshold of pressure pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of saccadic latency over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of anti-saccadic error rates over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of smooth pursuit speed over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neurologic Deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: VAP severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Ventilation Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ICU stay Total
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Behavioral BC Risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge of BC Risk
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Breast Self-examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endurance performance on a bike
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive impairment rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Disease-specific intestinal microbiome signatures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Localized and systemic immune responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Surgery Time difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Quality of Life (Scoliosis Research Society-22)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Size of Ventricular Septal Defect (VSD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Subjective happiness
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Perception of Stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of participants with reduced frailty score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental Health Literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Stigma Scale for Mental Illnesses
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in post vaccination SARS-CoV-2 neutralizing antibody level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bone marrow fat fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Laboratory-based AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of positive neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean titer of glycoprotein E-specific total IgG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in caregiver-reported respiratory symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Onset of active stage of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Conversion to sinus rhythm for a minimum duration of 30 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Post-ERCP Sepsis
Endpoint domain: Adverse events/effects